The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice

Neuropharmacology

Volumn 84, Issue , 2014, Pages 13-18

  Zheng, Dong ^a,b   Li, Yi ^a   He, Lei ^a   Tang, Yamei ^a   Li, Xiangpen ^a   Shen, Qingyu ^a   Yin, Deling ^c   Peng, Ying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Psychiatric Hospital   (China)

^c East Tennessee State University   (United States)

Author keywords

Astaxanthin; Embryo; Ethanol

Indexed keywords

ASTAXANTHIN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR OTX; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA; ALCOHOL; CENTRAL DEPRESSANT AGENT; IL1B PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; NEUROPROTECTIVE AGENT; OTX1 PROTEIN, MOUSE; SOX2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FETAL ALCOHOL SYNDROME; FETUS; GENE EXPRESSION; INFLAMMATION; MORPHOLOGY; MOUSE; NEUROPROTECTION; NONHUMAN; OTX1 GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SOX2 GENE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FETAL ALCOHOL SPECTRUM DISORDERS; FETUS DEVELOPMENT; METABOLISM; PHYSIOLOGY; PREGNANCY; RANDOMIZATION;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; ETHANOL; FEMALE; FETAL ALCOHOL SPECTRUM DISORDERS; FETAL DEVELOPMENT; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN-1BETA; MALONDIALDEHYDE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OTX TRANSCRIPTION FACTORS; OXIDATIVE STRESS; PREGNANCY; RANDOM ALLOCATION; SOXB1 TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; XANTHOPHYLLS;

EID: 84900474788     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.04.013     Document Type: Article

References (29)

1. B. Ahluwalia, B. Wesley, O. Adeyiga, D.M. Smith, A. Da-Silva, and S. Rajguru Alcohol modulates cytokine secretion and synthesis in human fetus: an in vivo and in vitro study Alcohol 21 2000 207 213
2. A.M. Blanco, M. Pascual, S.L. Valles, and C. Guerri Ethanol-induced iNOS and COX-2 expression in cultured astrocytes via NF-kappa B Neuroreport 15 2004 681 685
3. G.N. Coral-Hinostroza, T. Ytrestøyl, B. Ruyter, and B. Bjerkeng Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acyl diesters Comp. Biochem. Physiol. C Toxicol. Pharmacol. 139 2004 99 110
4. R.G. Fassett, and J.S. Coombes Astaxanthin, oxidative stress, inflammation and cardiovascular disease Future Cardiol. 5 2009 333 342
5. R.G. Fassett, and J.S. Coombes Astaxanthin: a potential therapeutic agent in cardiovascular disease Mar. Drugs 9 2011 447 465
6. M. Guerin, M.E. Huntley, and M. Olaizola Haematococcus astaxanthin: applications for human health and nutrition Trends. Biotechnol. 21 2003 210 216
7. M.B. Heaton, M. Paiva, J. Mayer, and R. Miller Ethanol-mediated generation of reactive oxygen species in developing rat cerebellum Neurosci. Lett. 334 2002 83 86
8. G.I. Henderson, B.G. Devi, A. Perez, and S. Schenker In utero ethanol exposure elicits oxidative stress in the rat fetus Alcohol. Clin. Exp. Res. 19 1995 714 720
9. G. Hussein, U. Sankawa, H. Goto, K. Matsumoto, and H. Watanabe Astaxanthin, a carotenoid with potential in human health and nutrition J. Nat. Prod. 69 2006 443 449
10. P. Kidd Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential Altern. Med. Rev. 16 2011 355 364
11. M. Kurashige, E. Okimasu, M. Inoue, and K. Utsumi Inhibition of oxidative injury of biological membranes by astaxanthin Physiol. Chem. Phys. Med. NMR 22 1990 27 38
12. L. Long, Y. Li, Y.D. Wang, Q.Y. He, M. Li, X.D. Cai, K. Peng, X.P. Li, D. Xie, Y.L. Wen, D.L. Yin, and Y. Peng The preventive effect of oral EGCG in a fetal alcohol spectrum disorder mouse model Alcohol. Clin. Exp. Res. 34 2010 1929 1936
13. C. Mallard, X. Wang, and H. Hagberg The role of Toll-like receptors in perinatal brain injury Clin. Perinatol. 36 2009 763 772 v-vi
14. J. Mercke-Odeberg, A. Lignell, A. Pettersson, and P. Höglund Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations Eur. J. Pharm. Sci. 19 2003 299 304
15. G. Michailidis, A. Theodoridis, and M. Avdi Transcriptional profiling of Toll-like receptors in chicken embryos and in the ovary during sexual maturation and in response to Salmonella enteritidis infection Anim. Reprod. Sci. 122 3-4 2010 Dec 294 302
16. M. ∅sterlie, B. Bjerkeng, and S. Liaaen-Jensen Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin J. Nutr. Biochem. 11 2000 482 490
17. P. Palozza, and N.I. Krinsky Astaxanthin and canthaxanthin are potent antioxidants in a membrane model Arch. Biochem. Biophys. 297 1992 291 295
18. C. Papanayotou, A. Mey, A.M. Birot, Y. Saka, S. Boast, J.C. Smith, J. Samarut, and C.D. Stern A mechanism regulating the onset of Sox2 expression in the embryonic neural plate PLoS. Biol. 6 2008 e2
19. Y. Peng, K.H. Kwok, P.H. Yang, S.S. Ng, J. Liu, O.G. Wong, M.L. He, H.F. Kung, and M.C. Lin Ascorbic acid inhibits ROS production, NF-κB activation and prevents ethanol-induced growth retardation and microencephaly Neuropharmacology 48 2005 426 434
20. P.D. Sampson, A.P. Streissguth, F.L. Bookstein, R.E. Little, S.K. Clarren, P. Dehaene, J.W. Hanson, and J.M. Graham Jr. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder Teratology 56 1997 317 326
21. S.D. Santos, T.B. Cahú, G.O. Firmino, C.C. de Castro, L.B. Carvalho Jr., R.S. Bezerra, and J.L. Filho Shrimp waste extract and astaxanthin: rat alveolar macrophage, oxidative stress and inflammation J. Food Sci. 77 2012 H141 H146
22. A. Simeone, D. Acampora, A. Mallamaci, A. Stornaiuolo, M.R. D'Apice, V. Nigro, and E. Boncinelli A vertebrate gene related to orthodenticle contains a homeodomain of the bicoid class and demarcates anterior neuroectoderm in the gastrulating mouse embryo EMBO. J. 12 1993 2735 2747
23. F. Sozo, L. O'Day, G. Maritz, K. Kenna, V. Stacy, N. Brew, D. Walker, A. Bocking, J. Brien, and R. Harding Repeated ethanol exposure during late gestation alters the maturation and innate immune status of the ovine fetal lung Am. J. Physiol. Lung Cell. Mol. Physiol. 296 2009 L510 L518
24. G.A. Spiller, and A. Dewell Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial J. Med. Food 6 2003 51 56
25. F.Y. Tanga, N. Nutile-McMenemy, and J.A. DeLeo The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy PNAS 102 2005 5856 5861
26. R.M. Vabulas, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. Issels, and H. Wagner HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway J. Biol. Chem. 277 2002 15107 15112
27. S.L. Vallés, A.M. Blanco, M. Pascual, and C. Guerri Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes Brain Pathol. 14 2004 365 371
28. H.J. Wang, S. Zakhari, and M.K. Jung Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development World. J. Gastroenterol. 16 2010 1304 1313
29. D.J. Wattendorf, and M. Muenke Fetal alcohol spectrum disorders Am. Fam. Phys. 72 2005 279 282